We are Sorry, This Page doesn't Exist

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vac.....»»

Earlier this week, Good Company Brands announced the launch of its first suite of products: Good Company Tea. 0 read more.....»»

U.S. IPO Week Ahead: A Flurry Of IPOs Expected To Launch July Roadshows.....»»

Biotech stocks staged a recovery this week after being in the red in the previous two weeks. AbbVie Inc (NYSE: ABBV)'s psoriasis drug Skyrizi received FDA nod. The week also saw the release of strong quarterly earnings by big European pharma gian.....»»

Lyft plans to launch the roadshow next week leading up to one of the largest and most highly anticipated IPOs in recent years. Here’s a look at what an IPO roadshow is and what investors can expect. read more.....»»

Below is a list of notable corporate events for the week beginning June 18. Note, this list is not comprehensive and all dates are subject to change. All times are ET. Monday Conferences Blockchain Economic Forum June 16-19 FDA/Biotech Latest Rat.....»»

There are no deals set to price.....»»

U.S. IPO Week Ahead: No IPOs Expected, But Over 10 Deals Could Launch.....»»

Biotech stocks.....»»

Biotech stocks are staging a rebound following the losses incurred in the week ended Oct. 12 amid catalysts that include the third-quarter earnings s.....»»

Two Stanford University scientists, Dr. Jonathan Rothbard and Professor Lawrence Steinman, announced this week they've joined forces to launch the medical cannabis company Katexco Pharmaceuticals. read more.....»»

Large-cap pharma stocks are seeing some upward momentum and are on track to finish the year with handsome gains. As the year draws to a close, it remains to be see.....»»

Large-cap pharma stocks are seeing some upward momentum and are on track to f.....»»

The earnings season hasn't panned out well for pharma companies, with Amgen, Inc. (NASDAQ: AMGN), Novartis AG (NYS.....»»

The earnings season hasn't panned out well for pharma companies, with Amgen, Inc. (NASDAQ: AMGN), Novartis AG (NYSE: NVS) and Illumina, Inc. read more.....»»

The launch of Boeing's Starliner capsule with two astronauts aboard to the International Space Station was delayed until at least next week after NASA decided to replace a faulty valve on the Atlas V rocket that would bl.....»»

The decision to launch the BYD Shark in Mexico indicates the company's focus on foreign markets, as pickup trucks in China are classified as light vans and face numerous restrictions read more.....»»

The Boston-based developer opened its “Top of the Tower” venue space at the top of the tallest tower in Worcester with a launch party this week......»»

In this week’s Petri Dish we’ll take a look at a new Cambridge company founded by gene-editing experts that emerged with some big funding, as well as Foghorn Therapeutics’ new CFO and the awardees of $2.8 million in women's health funding......»»